BlackRock Institutional Trust’s Kyntra Bio KYNB Stock Holding History

BlackRock Institutional Trust’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$33.1M	Buy	61,937 +3,960	+7%	+$1.98M	﹤0.01%	1600
2016 Q3	$30M	Buy	57,977 +6,502	+13%	+$3.06M	﹤0.01%	1605
2016 Q2	$21.1M	Buy	51,475 +2,792	+6%	+$1.28M	﹤0.01%	1812
2016 Q1	$25.9M	Sell	48,683 -946	-2%	-$471K	﹤0.01%	1634
2015 Q4	$37.8M	Sell	49,629 -877	-2%	-$582K	0.01%	1434
2015 Q3	$27.7M	Buy	50,506 +31,387	+164%	+$19M	﹤0.01%	1603
2015 Q2	$11.2M	Buy	19,119 +15,799	+476%	+$9.19M	﹤0.01%	2332
2015 Q1	$2.6M	Buy	3,320 +81	+3%	+$62.8K	﹤0.01%	2991
2014 Q4	$2.21M	Buy	+3,239	New	+$2.08M	﹤0.01%	3058

Other funds holding KYNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

BlackRock Institutional Trust's KYNB Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Kyntra Bio (KYNB) stake by 6.8% in Q4 2016, buying an estimated $1.98M and bringing the position to 61,937 shares worth $33.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1600.

BlackRock Institutional Trust first reported a position in KYNB in Q4 2014 and has held it in 9 quarters since. The position peaked at $37.8M in Q4 2015. 140 funds tracked by Wall St. Rank hold KYNB as of Q4 2016.

BlackRock Institutional Trust held 61,937 shares of Kyntra Bio worth $33.1M as of Q4 2016.
BlackRock Institutional Trust bought 3,960 Kyntra Bio shares in Q4 2016, an estimated $1.98M.
Kyntra Bio made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1600 holding.
BlackRock Institutional Trust first reported a position in Kyntra Bio in Q4 2014 and has held it in 9 quarters since.
BlackRock Institutional Trust's Kyntra Bio position peaked at $37.8M in Q4 2015.
140 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.